Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Sell
24
FLWS Quote, Financials, Valuation and Earnings
Last price:
$5.70
Seasonality move
:
-0.49%
Day range:
$5.43 - $5.76
52-week range:
$4.96 - $11.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.21x
P/B ratio:
0.72x
Volume:
538.3K
Avg. volume:
582.8K
1-year change:
-36.1%
Market cap:
$356.8M
Revenue:
$1.8B
EPS (TTM):
-$0.11
Analysts' Opinion
-
Consensus Rating1-800-Flowers.com has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.50, 1-800-Flowers.com has an estimated upside of 87.17% from its current price of $5.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $5.61.
Fair Value
-
According to the consensus of 1 analyst, 1-800-Flowers.com has 87.17% upside to fair value with a price target of $10.50 per share.
FLWS vs. S&P 500
-
Over the past 5 trading days, 1-800-Flowers.com has overperformed the S&P 500 by 2.14% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
1-800-Flowers.com does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
1-800-Flowers.com revenues have been falling on a year-over-year basis for 12 quarters in a row. In the most recent quarter 1-800-Flowers.com reported revenues of $775.5M.
Earnings Growth
-
1-800-Flowers.com has grown year-over-year earnings for 1 quarter straight. In the most recent quarter 1-800-Flowers.com reported earnings per share of $1.00.
Enterprise value:
267.1M
EV / Invested capital:
--
Price / LTM sales:
0.21x
EV / EBIT:
115.10x
EV / Revenue:
0.15x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-25.92x
Price / Operating cash flow:
29.15x
Enterprise value / EBITDA:
5.41x
Gross Profit (TTM):
$705M
Return On Assets:
-0.7%
Net Income Margin (TTM):
-0.43%
Return On Equity:
-1.6%
Return On Invested Capital:
-1.14%
Operating Margin:
11.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.2B | $1.9B | $1.8B | $822.1M | $775.5M | |
| Gross Profit | $787M | $745.9M | $705M | $355.7M | $335.6M | |
| Operating Income | $20.5M | $29.2M | -$11.6M | $111M | $91.1M | |
| EBITDA | $63.5M | $1.4M | $49.4M | $108.1M | $106.4M | |
| Diluted EPS | $0.05 | -$0.96 | -$0.11 | $0.97 | $1.00 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $563.4M | $572.9M | $468.7M | $544.5M | $492.9M | |
| Total Assets | $1.2B | $1.3B | $1.2B | $1.2B | $1.1B | |
| Current Liabilities | $416.7M | $420.9M | $344.3M | $341.9M | $325.6M | |
| Total Liabilities | $724.7M | $756.4M | $656.5M | $688.4M | $642.7M | |
| Total Equity | $497.6M | $565M | $560.5M | $503.4M | $495.1M | |
| Total Debt | $185.9M | $171.8M | $152.8M | $191.7M | $157.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $13M | $134.5M | $33.5M | $356.6M | $328.5M | |
| Cash From Investing | -$60.1M | -$44.8M | -$50.5M | -$10.8M | -$10.9M | |
| Cash From Financing | -$34.2M | $32.6M | -$47.8M | -$42.2M | -$78.8M | |
| Free Cash Flow | -$44.6M | $95.8M | -$10.3M | $345.8M | $317.6M | |
FLWS
Sector
Market Cap
$356.8M
$395M
Price % of 52-Week High
50.54%
67.19%
Dividend Yield
0%
0%
Shareholder Yield
5.3%
4.04%
1-Year Price Total Return
-36.11%
-17.54%
Beta (5-Year)
1.583
0.786
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.54
200-day SMA
Sell
Level
$7.70
Bollinger Bands (100)
Sell
Level
5.74 - 8.16
Chaikin Money Flow
Buy
Level
23M
20-day SMA
Buy
Level
$5.41
Relative Strength Index (RSI14)
Sell
Level
49.88
ADX Line
Buy
Level
16.78
Williams %R
Neutral
Level
-33.3333
50-day SMA
Sell
Level
$5.88
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9791)
Buy
CA Score
(Annual)
Level (0.0174)
Buy
Beneish M-Score
(Annual)
Level (-3.1099)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.9255)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
Stock Forecast FAQ
In the current month, FLWS has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FLWS average analyst price target in the past 3 months is $10.50.
-
Where Will 1-800-Flowers.com Stock Be In 1 Year?
According to analysts, the consensus estimate is that 1-800-Flowers.com share price will rise to $10.50 per share over the next 12 months.
-
What Do Analysts Say About 1-800-Flowers.com?
Analysts are divided on their view about 1-800-Flowers.com share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 1-800-Flowers.com is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is 1-800-Flowers.com's Price Target?
The price target for 1-800-Flowers.com over the next 1-year time period is forecast to be $10.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FLWS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for 1-800-Flowers.com is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of FLWS?
You can purchase shares of 1-800-Flowers.com via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 1-800-Flowers.com shares.
-
What Is The 1-800-Flowers.com Share Price Today?
1-800-Flowers.com was last trading at $5.70 per share. This represents the most recent stock quote for 1-800-Flowers.com. Yesterday, 1-800-Flowers.com closed at $5.61 per share.
-
How To Buy 1-800-Flowers.com Stock Online?
In order to purchase 1-800-Flowers.com stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 15.89% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0.09% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 20.88% over the past day.
